Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Lucas

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older womenNeil Carleton, Sanghoon Lee, Ruxuan Li, et al.
Journal of the National Cancer Institute|July 3, 2018
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable TargetsDamir Varešlija, Nolan Priedigkeit, Ailís Fagan, et al.
Nature|May 6, 2026
Non-invasive profiling of the tumour microenvironment with spatial ecotypesWubing Zhang, Erin L Brown, Abul Usmani, et al.
European Urology|April 19, 2025
Renal Neoplasia in Birt-Hogg-Dubé Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic AnalysisSounak Gupta, Surendra Dasari, Rachel R Warren, et al.
The New England Journal of Medicine|June 4, 2025
Omitting Regional Nodal Irradiation after Response to Neoadjuvant ChemotherapyEleftherios P Mamounas, Hanna Bandos, Julia R White, et al.
Nature Cancer|June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacyDong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
The New England Journal of Medicine|June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast CancerAndrew N J Tutt, Judy E Garber, Bella Kaufman, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older womenNeil Carleton, Sanghoon Lee, Ruxuan Li, et al.
Journal of the National Cancer Institute|July 3, 2018
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable TargetsDamir Varešlija, Nolan Priedigkeit, Ailís Fagan, et al.
Nature|May 6, 2026
Non-invasive profiling of the tumour microenvironment with spatial ecotypesWubing Zhang, Erin L Brown, Abul Usmani, et al.
European Urology|April 19, 2025
Renal Neoplasia in Birt-Hogg-Dubé Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic AnalysisSounak Gupta, Surendra Dasari, Rachel R Warren, et al.
The New England Journal of Medicine|June 4, 2025
Omitting Regional Nodal Irradiation after Response to Neoadjuvant ChemotherapyEleftherios P Mamounas, Hanna Bandos, Julia R White, et al.
Nature Cancer|June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacyDong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
The New England Journal of Medicine|June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast CancerAndrew N J Tutt, Judy E Garber, Bella Kaufman, et al.
Cancer Research|January 26, 2022
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer MetastasisZheqi Li, Yang Wu, Megan E Yates, et al.
Pageof 12